Paul Chaplin steps down as CEO of Bavarian Nordic

Paul Chaplin has worked at Bavarian Nordic since 1999 and has served as CEO since 2014. He will continue in the role for the remainder of the year, or until a successor has been appointed.

“Under his leadership, Bavarian Nordic has grown from a small research-based company with a single government customer to a large vaccine manufacturer with strong commercial operations in key markets. This growth has been made possible through strategic acquisition of travel vaccines, excellent tech transfer capability, and a successful commercial transformation of Bavarian Nordic”, the company writes in a press release.